Arrowhead Pharma Earnings Surprises image   This ARWR earnings surprises page last updated 3/11/2024
Arrowhead Pharma Earnings Surprises Chart
PeriodExpectedActualSurprise
Q1 2024 -0.82 -1.24 -0.42 (+51%)
Q4 2023 -0.60 -1.02 -0.42 (+70%)
Q3 2023 -0.58 -0.96 -0.38 (+66%)
Q2 2023 -0.64 0.45 +1.09 (-170%)
Q1 2023 0.44 -0.39 -0.83 (-189%)
Q4 2022 -0.16 -0.81 -0.65 (+406%)
Q3 2022 -0.51 -0.68 -0.17 (+33%)
Q2 2022 -0.08 0.41 +0.49 (-612%)
Q1 2022 -0.45 -0.60 -0.15 (+33%)
Q4 2021 -0.10 -0.61 -0.51 (+510%)
Q3 2021 -0.20 -0.29 -0.09 (+45%)
Q2 2021 -0.13 -0.26 -0.13 (+100%)
Q1 2021 0.17 -0.20 -0.37 (-218%)
Q4 2020 0.12 -0.48 -0.60 (-500%)
Q3 2020 -0.12 -0.13 -0.01 (+8%)
Q2 2020 -0.11 -0.20 -0.09 (+82%)
Q1 2020 -0.01 -0.03 -0.02 (+200%)
Q3 2019 0.29 0.21 -0.08 (-28%)
Q2 2019 0.19 0.24 +0.05 (+26%)
Q1 2019 0.54 0.13 -0.41 (-76%)
Q2 2018 -0.19 -0.18 +0.01 (-5%)
Q1 2018 -0.16 -0.18 -0.02 (+12%)
Q4 2017 -0.10 -0.15 -0.05 (+50%)
Q3 2017 -0.14 -0.07 +0.07 (-50%)
Q2 2017 -0.12 -0.08 +0.04 (-33%)
Q4 2016 -0.32 -0.34 -0.02 (+6%)
Q3 2016 -0.37 -0.32 +0.05 (-14%)
Q2 2016 -0.37 -0.35 +0.02 (-5%)
Q1 2016 -0.41 -0.32 +0.09 (-22%)
Q4 2015 -0.39 -0.41 -0.02 (+5%)
Q3 2015 -0.38 -0.27 +0.11 (-29%)
Q2 2015 -0.34 -0.51 -0.17 (+50%)
Q1 2015 -0.34 -0.41 -0.07 (+21%)
Q2 2014 -0.20 0.31 +0.51 (-255%)
Q1 2013 -0.20 -0.28 -0.08 (+40%)
Arrowhead Pharma Revenue Surprises Chart
PeriodExpectedActualSurprise
Q1 2024 29.51M 3.55M -25.96M (-88%)
Q4 2023 50.73M 16.10M -34.63M (-68%)
Q3 2023 48.19M 15.82M -32.37M (-67%)
Q2 2023 45.48M 146.27M +100.79M (+222%)
Q1 2023 162.52M 62.55M -99.97M (-62%)
Q4 2022 50.44M 31.57M -18.86M (-37%)
Q3 2022 55.23M 32.41M -22.82M (-41%)
Q2 2022 108.91M 151.81M +42.90M (+39%)
Q1 2022 51.04M 27.44M -23.60M (-46%)
Q4 2021 56.77M 38.28M -18.49M (-33%)
Q3 2021 37.52M 45.89M +8.37M (+22%)
Q2 2021 37.70M 32.81M -4.89M (-13%)
Q1 2021 86.69M 21.30M -65.39M (-75%)
Q4 2020 49.24M 7.63M -41.61M (-85%)
Q3 2020 28.91M 27.38M -1.53M (-5%)
Q2 2020 21.74M 23.53M +1.79M (+8%)
Q1 2020 29.50M 29.45M -45000 (-0%)
Q3 2019 54.37M 42.70M -11.67M (-21%)
Q2 2019 42.56M 48.15M +5.59M (+13%)
Q1 2019 74.76M 34.66M -40.10M (-54%)
Q2 2018 1.85M 650125 -1.20M (+35141792%)
Q1 2018 7.27M 3.51M -3.76M (-52%)
Q4 2017 9.10M 8.71M -0.39M (-4%)
Q3 2017 5.13M 9.34M +4.21M (+82%)
Q2 2017 5.51M 8.99M +3.48M (+63%)
Q4 2016 30000 31250 +1250 (+4%)
Q3 2016 60000 39583 -20417 (-34%)
Q2 2016 70000 43750 -26250 (-38%)
Q1 2016 130000 43750 -86250 (-66%)
Q4 2015 150000 43750 -0.11M (-71%)
Q3 2015 110000 123750 +13750 (+12%)
Q2 2015 110000 43750 -66250 (-60%)
Q1 2015 40000 170750 +130750 (+327%)
Q2 2014 40000 43750 +3750 (+9%)
Q1 2013 50000 48000 -2000 (-4%)
Quotes delayed 20 minutes

Email EnvelopeFree ARWR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 3/11/2024 7:00 AM
Overseas Shipholding Gr (OSG): 3/11/2024 7:30 AM
Genie Energy (GNE): 3/11/2024 7:30 AM
Curis (CRIS): 3/11/2024 8:00 AM
Ocular Therapeutix (OCUL): 3/11/2024 After close
Ranpak Hldgs (PACK): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Assertio Holdings (ASRT): 3/11/2024 After close
Amylyx Pharma (AMLX): 3/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

Cue Biopharma (CUE): 3/9/2024 After close
Ovid Therapeutics (OVID): 3/8/2024 8:00 AM
America's Car-Mart (CRMT): 3/8/2024 8:00 AM
Sigmatron International (SGMA): 3/8/2024 8:00 AM
XOMA (XOMA): 3/8/2024 7:30 AM
Dixie Gr (DXYN): 3/8/2024 7:00 AM
Genesco (GCO): 3/8/2024 6:50 AM
Nine Energy Service (NINE): 3/7/2024 5:00 PM
Ring Energy (REI): 3/7/2024 After close
Team (TISI): 3/7/2024 After close

More from the Earnings History archive
Arrowhead Pharma (ARWR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ASMB Historical Earnings
ASRT Historical Earnings
ATEC Historical Earnings
ATHA Historical Earnings
ATHX Historical Earnings
ATIP Historical Earnings
ATNF Historical Earnings
ATNX Historical Earnings
ATOS Historical Earnings
ATRA Historical Earnings
On this page we presented the ARWR earnings surprises information for Arrowhead Pharma, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on ARWR (or any other given stock) can benefit from researching all of the Arrowhead Pharma past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Arrowhead Pharma earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about ARWR's next earnings report. In your continued research on Arrowhead Pharma we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for ARWR. Thanks for visiting, and the next time you need to research ARWR earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Institutional Holders of BKMC, CUNB Price Target, PGAL Dividend History.

 

Arrowhead Pharma Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.